Excerpt: The new drug, an OX40 fusion protein called OX40:Ig, works by binding to the OX40 receptor and blocking activated T-cells. OX40:Ig, supplied by the company Xenova Research, stopped the symptoms of flu in mice.
it's more accurate to say stopped symptoms assocciated with with cytokine storm. The influenza symptoms are resultant and present because of a different mechanism